Breaking News Bar

Business News and Information

Dicerna Pharmaceutic (NQ: DRNA )

24.64 USD +1.61 (+6.99%)

Official Closing Price Updated: 5:01 PM EST, Jan 22, 2021 Add to My Watchlist

Price and Volume

Volume	844,300
Open	23.01
Bid (Size)	23.60 (2)
Ask (Size)	25.65 (6)
Prev. Close	23.03
Today's Range	23.00 - 24.79
52wk Range	11.75 - 27.10
Shares Outstanding	52,821,624
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Dicerna to Participate in the H.C. Wainwright Virtual BioConnect Conference

January 05, 2021

Dicerna announced that Doug Fambrough will participate in two events at the H.C. Wainwright Virtual BioConnect Conference taking place Jan. 11-14.

Dicerna Announces Novo Nordisk’s Nomination of First Candidate for Development Under RNAi Discovery and Development Agreement and Additional Milestone Achievement

January 05, 2021

Dicerna announced that Novo Nordisk has nominated its first candidate for development under the existing agreement between the two companies.

Performance

YTD	+11.64%	+11.64%
1 Month	+5.16%	+5.16%
3 Month	+21.26%	+21.26%
6 Month	+5.98%	+5.98%
1 Year	+27.93%	+27.93%

More News

Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 04, 2021

Dicerna Announces Enrollment Completion of PHYOX™2 Pivotal Trial of Nedosiran for Treatment of Primary Hyperoxaluria

January 04, 2021

Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 01, 2020

Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020

November 16, 2020

Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for First GalXC™ RNAi Candidate Under Companies’ Global Research Collaboration and Licensing Agreement

November 16, 2020

Dicerna to Participate in Upcoming Investor Conferences

November 11, 2020

PBE's Holdings Imply 11% Gain Potential

December 30, 2020

Dicerna Presents New Nonclinical Research Highlighting the Application of its RNAi Technology in Extrahepatic Tissues at TIDES Europe 2020

November 10, 2020

First Week of DRNA February 2021 Options Trading

December 18, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

bottom clear

About Us